{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:21:28Z","timestamp":1759483288787,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As the coronavirus disease 2019 (COVID-19) pandemic is ongoing and new variants of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging, there is an urgent need for vaccines to protect individuals at high risk for complications and to potentially control disease outbreaks by herd immunity. Surveillance of rare safety issues related to these vaccines is progressing, since more granular data emerge about adverse events of SARS-CoV-2 vaccines during post-marketing surveillance. Varicella zoster virus (VZV), Epstein-Barr virus (EBV) and cytomegalovirus (CMV) reactivation has already been reported in COVID-19 patients. In addition, adverse events after SARS-CoV-2 mRNA vaccination have also been in the context of varicella zoster virus (VZV) reactivation and directly associated with the mRNA vaccine. We present the first case of CMV reactivation and pericarditis in temporal association with SARS-CoV-2 vaccination, particularly adenovirus-based DNA vector vaccine ChAdOx1 nCoV-19 against SARS-CoV-2. After initiation of antiviral therapy with oral valganciclovir, CMV viremia disappeared and clinical symptoms rapidly improved. Since huge vaccination programs are ongoing worldwide, post-marketing surveillance systems must be in place to assess vaccine safety that is important for the detection of any events. In the context of the hundreds of millions of individuals to be vaccinated against SARS-CoV-2, a potential causal association with CMV reactivation may result in a considerable number of cases with potentially severe complications.<\/jats:p>","DOI":"10.3389\/fimmu.2021.784145","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T04:29:52Z","timestamp":1642480192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2"],"prefix":"10.3389","volume":"12","author":[{"given":"Marlene","family":"Pl\u00fc\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Mese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes T.","family":"Kowallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Tampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/vaccines9050433","article-title":"An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times","volume":"9","author":"Garcia-Montero","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A Guide to Vaccinology: From Basic Principles to New Developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e8998","DOI":"10.7759\/cureus.8998","article-title":"Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19","volume":"12","author":"Saati","year":"2020","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14361","article-title":"COVID-19 and Herpes Zoster Co-Infection Presenting With Trigeminal Neuropathy","volume":"27","author":"Ferreira","year":"2020","journal-title":"Eur J Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15001","article-title":"Herpes Zoster in COVID-19-Positive Patients","volume":"59","author":"Tartari","year":"2020","journal-title":"Int J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0133","article-title":"Herpes Zoster May be a Marker for COVID-19 Infection During Pregnancy","volume":"106","author":"Elsaie","year":"2020","journal-title":"Cutis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"EBV DNA Increase in COVID-19 Patients With Impaired Lymphocyte Subpopulation Count","volume":"104","author":"Paolucci","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13054-020-03252-3","article-title":"Herpes Simplex Virus and Cytomegalovirus Reactivations Among Severe COVID-19 Patients","volume":"24","author":"Le Balc'h","year":"2020","journal-title":"Crit Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e00962","DOI":"10.1016\/j.idcr.2020.e00962","article-title":"Cytomegalovirus Enterocolitis Secondary to Experimental COVID-19 Therapy","volume":"22","author":"Geisen","year":"2020","journal-title":"IDCases"},{"key":"B11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/vaccines9060572","article-title":"Reactivation of Varicella Zoster Virus After Vaccination for SARS-CoV-2","volume":"9","author":"Psichogiou","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-Zoster Virus Reactivation After SARS-CoV-2 BNT162b2 mRNA Vaccination: Report of 5 Cases","volume":"12","author":"Rodriguez-Jimenez","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.013","article-title":"Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial","volume":"67","author":"Lurz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis Following COVID-19 mRNA Vaccination","volume":"39","author":"Abu Mouch","year":"2021","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis With COVID-19 mRNA Vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"ytab319","DOI":"10.1093\/ehjcr\/ytab319","article-title":"Case Report: Acute Myocarditis Following the Second Dose of mRNA-1273 SARS-CoV-2 Vaccine","volume":"5","author":"Tailor","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.05.033","article-title":"Myocarditis Following COVID-19 Vaccination","volume":"16","author":"Albert","year":"2021","journal-title":"Radiol Case Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2021052478","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination","volume":"148","author":"Marshall","year":"2021","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.ahjo.2021.100042","article-title":"Myocarditis Following mRNA Vaccination Against SARS-CoV-2, a Case Series","volume":"8","author":"King","year":"2021","journal-title":"Am Heart J Plus"},{"key":"B21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3238\/arztebl.m2021.0288","article-title":"Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19","volume":"118","author":"Vollmann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and Pericarditis After Vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"Jama"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2021052644","DOI":"10.1542\/peds.2021-052644","article-title":"Myocarditis After SARS-CoV-2 Vaccination: True, True, and... Related","volume":"148","author":"O'Leary","year":"2021","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199504000-00009","article-title":"Cytomegalovirus Pericarditis: A Case Series and Review of the Literature","volume":"309","author":"Campbell","year":"1995","journal-title":"Am J Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.642500","article-title":"Latent Cytomegalovirus Reactivation in Patients With Liver Failure: A 10-Year Retrospective Case-Control Study, 2011-2020","volume":"11","author":"Yang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655","article-title":"Review of Cytomegalovirus Seroprevalence and Demographic Characteristics Associated With Infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","article-title":"Congenital Cytomegalovirus Infection: Advances and Challenges in Diagnosis, Prevention and Treatment","volume":"43","author":"Marsico","year":"2017","journal-title":"Ital J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of Human Cytomegalovirus in the Immunocompromised Host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B29","article-title":"Infectious Mononucleosis and Mononucleosis Syndromes","volume":"126","author":"Fiala","year":"1977","journal-title":"West J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human Cytomegalovirus: Clinical Aspects, Immune Regulation, and Emerging Treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and Human Vaccine Immune Responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 Vaccine BNT162b1 Elicits Human Antibody and TH1 T Cell Responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1086\/515019","article-title":"High Incidence of Herpes Zoster in Patients With AIDS Soon After Therapy With Protease Inhibitors","volume":"27","author":"Martinez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218836","article-title":"Correspondence on 'Interleukin-6 Receptor Blockade With Subcutaneous Tocilizumab in Severe COVID-19 Pneumonia and Hyperinflammation: Case-Control Study'","author":"Winkler","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1186\/s12913-020-06001-y","article-title":"Persistent Symptoms After Covid-19: Qualitative Study of 114 \"Long Covid\" Patients and Draft Quality Principles for Services","volume":"20","author":"Ladds","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.784145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T04:29:56Z","timestamp":1642480196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.784145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2021.784145"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.784145","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"article-number":"784145"}}